Literature DB >> 27587354

Beyond the Surface: Care Seeking Among Patients Initiating Contraceptive Implant in an Urban Federally Qualified Health Center Network.

Anita Ravi1, Linda Prine2, Gabrielle deFiebre3, Susan E Rubin4.   

Abstract

PURPOSE: To describe rates of and reasons for follow-up among adolescents and adults receiving contraceptive implants in a Federally Qualified Health Center (FQHC).
METHODS: Retrospective comparison of patient-initiated implant-related contacts during the 6 months postinsertion among adolescents (110) and adults (154) who had implants placed at a FQHC network.
RESULTS: Forty percent of adolescents and 26% of adults initiated follow-up ( P = .016). Bleeding changes and discussing removal were the most common reasons for follow-up for both groups. Adolescents (5.5%) and adults (9.0%) had similar removal rates ( P = .348). However, among patients who discussed implant removal, adults were more likely to have removals compared with adolescents ( P = .002).
CONCLUSIONS: Other FQHCs may anticipate a similar experience to ours, where adolescents may be more likely than adults to initiate implant-related follow up, with removal rates of less than 10% at 6 months. Further study of physician decision making and patient autonomy regarding implantable contraception removal requests is warranted.

Entities:  

Keywords:  FQHC; adolescent; community health centers; contraception; implantable contraception; primary care

Year:  2016        PMID: 27587354      PMCID: PMC5932654          DOI: 10.1177/2150131916666011

Source DB:  PubMed          Journal:  J Prim Care Community Health        ISSN: 2150-1319


  24 in total

1.  Federally qualified health center expansion through the Affordable Care Act.

Authors:  E Benjamin Money
Journal:  N C Med J       Date:  2013 Jul-Aug

2.  Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.

Authors:  Caroline Harvey; Charrlotte Seib; Jayne Lucke
Journal:  Contraception       Date:  2009-07-10       Impact factor: 3.375

3.  Scope of family planning services available in Federally Qualified Health Centers.

Authors:  Susan Wood; Tishra Beeson; Brian Bruen; Debora Goetz Goldberg; Holly Mead; Peter Shin; Sara Rosenbaum
Journal:  Contraception       Date:  2013-10-01       Impact factor: 3.375

4.  Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.

Authors: 
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

5.  "I think it depends on the body, with mine it didn't work": explaining young women's contraceptive implant removal.

Authors:  Lesley Hoggart; Victoria Louise Newton; Jane Dickson
Journal:  Contraception       Date:  2013-06-05       Impact factor: 3.375

6.  Bleeding related to etonogestrel subdermal implant in a US population.

Authors:  Petra M Casey; Margaret E Long; Mary L Marnach; Jessica E Bury
Journal:  Contraception       Date:  2010-11-06       Impact factor: 3.375

7.  Accessibility of long-acting reversible contraceptives (LARCs) in Federally Qualified Health Centers (FQHCs).

Authors:  Tishra Beeson; Susan Wood; Brian Bruen; Debora Goetz Goldberg; Holly Mead; Sara Rosenbaum
Journal:  Contraception       Date:  2013-10-01       Impact factor: 3.375

8.  Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users.

Authors:  Renee C Wong; Robin J Bell; Kalyani Thunuguntla; Kathleen McNamee; Beverley Vollenhoven
Journal:  Contraception       Date:  2009-05-14       Impact factor: 3.375

9.  Twelve-month discontinuation of etonogestrel implant in an outpatient pediatric setting.

Authors:  Elise Berlan; Kelly Mizraji; Andrea E Bonny
Journal:  Contraception       Date:  2016-03-03       Impact factor: 3.375

10.  The effect of immediate postpartum compared to delayed postpartum and interval etonogestrel contraceptive implant insertion on removal rates for bleeding.

Authors:  Luu Doan Ireland; Vinita Goyal; Christina A Raker; Anne Murray; Rebecca H Allen
Journal:  Contraception       Date:  2014-05-24       Impact factor: 3.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.